| Bioactivity | CFTR corrector 2 is a cystic fibrosis transmembrane conductance corrector (CFTR), extracted from patent US20140274933[1]. | ||||||||||||
| Target | CFTR. | ||||||||||||
| Name | CFTR corrector 2 | ||||||||||||
| CAS | 1628416-28-3 | ||||||||||||
| Formula | C27H23FN4O4 | ||||||||||||
| Molar Mass | 486.49 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Bridget M. Cole, et al. PHTHALAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS. US20140274933. |
CFTR corrector 2
CAS: 1628416-28-3 F: C27H23FN4O4 W: 486.49
CFTR corrector 2 is a cystic fibrosis transmembrane conductance corrector (CFTR), extracted from patent US20140274933.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.